Inotiv, Inc.
NOTVInactive ticker- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000720154
No open-market purchases or sales by Inotiv, Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $332 in total; no superinvestor holds it.
This ticker is no longer on the SEC's list of tickers: the company may have been delisted, or the ticker has changed.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Inotiv, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Inotiv, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Brown Nigel | Director | 0 | Jul 20, 2026 | 1 |
| Taylor Beth | Chief Financial Officer | 0 | Jul 20, 2026 | 3 |
| Sagartz John E | Chief Strategy Officer | 0 | Jul 20, 2026 | 3 |
| Neff R Matthew | Director | 0 | Jul 20, 2026 | 5 |
| Landman David | Director | 0 | Jul 20, 2026 | 1 |
| Hardy Adrian | Chief Commercial Officer | 0 | Jul 20, 2026 | 2 |
| Harrington Michael J | Director | 0 | Jul 20, 2026 | 1 |
| Freeman Jeffrey Brennan | VP-Finance & Corp. Controller | 0 | Jul 20, 2026 | 2 |
| Coelho Mary Theresa | Director | 0 | Jul 20, 2026 | 1 |
| Castetter Andrea | EVP, GC, Sec'y & CCO | 0 | Jul 20, 2026 | 3 |
| Beattie John Gregory | Chief Operating Officer | 0 | Jul 20, 2026 | 2 |
| Leasure Robert Jr. | President and CEO | 0Indirect | Jul 20, 2026 | 3 |
| Krupp Jeffrey Arthur | Chief Human Resources Officer | 53,557 | Mar 18, 2025 | 0 |
| Beraldi Fernanda | Former Gen'l Counsel & Sec'y | 7,840 | Jan 10, 2024 | 0 |
| Garrett Michael | Chief Commercial Officer | 16,467 | Dec 15, 2023 | 0 |
| Johnson Richard Allen | Director | 97,780 | Apr 4, 2023 | 0 |
| Davis Gregory Cole | Director | 67,780 | Apr 4, 2023 | 0 |
| Pitchford William D | Chief Human Resources Officer | 74,051 | Dec 29, 2022 | 0 |
| Moller Claus J | 10% Owner | 63,758Indirect | Sep 20, 2022 | 0 |
| P2 Capital Partners, LLC | 10% Owner | 63,758Indirect | Sep 20, 2022 | 0 |
| P2 Capital Fund IV, L.P. | Other: Affiliate of 10% owner | 63,758Indirect | Sep 20, 2022 | 0 |
| Savanna Holdings, LLC | 10% Owner | 63,758Indirect | Sep 20, 2022 | 0 |
| P2 Capital Master Fund I, L.P. | Other: Affiliate of 10% owner | 63,758Indirect | Sep 20, 2022 | 0 |
| Baker Andrew H | 10% Owner | 1,806,690Indirect | Jul 1, 2022 | 0 |
| Jermyn Street Associates LLC | 10% Owner | 1,806,690Indirect | Jul 1, 2022 | 0 |
| Cragg Scott | Director | 4,715 | Apr 5, 2022 | 0 |
| Harkness James | Chief Operating Officer, RMS | 38,968 | Mar 16, 2022 | 0 |
| Bibi Mark L | General Counsel and Secretary | 58,134 | Mar 1, 2022 | 0 |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | 42,195 | Feb 23, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 (view filing)4:41 PM ET | Feb 17 | 2 days | Taylor BethChief Financial Officer | SSale | −2.89K | $0.2929 | −$845.9 | −1.9%145.5K after | 10b5-1 |
| Feb 19, 2026 (view filing)4:40 PM ET | Feb 17 | 2 days | Sagartz John EChief Strategy Officer | SSale | −2.12K | $0.2908 | −$616.21 | −0.3%735.7K after | 10b5-1 |
| Feb 19, 2026 (view filing)4:39 PM ET | Feb 17 | 2 days | Leasure Robert Jr.President and CEO | SSale | −16.8K | $0.2953 | −$4.96K | −1.3%1.26M after | 10b5-1 |
| Feb 3, 2026 (view filing) | Feb 2 | 1 day | Leasure Robert Jr.President and CEO | SSale | −113.3K | $0.50 | −$56.6K | −8.2%1.27M after | |
| Dec 2, 2025 (view filing) | Dec 1 | 1 day | Neff R MatthewDirector | SSale | −2.00K | $0.89 | −$1.78K | −1.3%151.1K after | 10b5-1 |
| Nov 4, 2025 (view filing) | Nov 3 | 1 day | Neff R MatthewDirector | SSale | −2.00K | $1.24 | −$2.48K | −1.3%153.1K after | 10b5-1 |
| Oct 3, 2025 (view filing) | Oct 1 | 2 days | Neff R MatthewDirector | SSale | −2.00K | $1.43 | −$2.86K | −1.4%145.1K after | 10b5-1 |
| Sep 4, 2025 (view filing) | Sep 2 | 2 days | Neff R MatthewDirector | SSale | −2.00K | $1.67 | −$3.34K | −1.3%147.1K after | |
| Aug 4, 2025 (view filing) | Aug 1 | 3 days | Neff R MatthewDirector | SSale | −2.00K | $1.91 | −$3.82K | −1.3%149.1K after | 10b5-1 |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Neff R MatthewDirector | SSale | −2.00K | $1.81 | −$3.62K | −1.3%151.1K after | 10b5-1 |
| Jun 4, 2025 (view filing) | Jun 2 | 2 days | Neff R MatthewDirector | SSale | −2.00K | $2.62 | −$5.24K | −1.3%153.1K after | 10b5-1 |
| Apr 2, 2025 (view filing) | Apr 1 | 1 day | Coelho Mary TheresaDirector | SSale | −5.50K | $2.35 | −$12.9K | −6.9%74.3K after | |
| Feb 20, 2025 (view filing) | Feb 18 | 2 days | Freeman Jeffrey BrennanVP-Finance & Corp. Controller | SSale | −1.34K | $4.05 | −$5.42K | −4.6%27.5K after | |
| Feb 20, 2025 (view filing) | Feb 18 | 2 days | Taylor BethChief Financial Officer | SSale | −4.37K | $4.01 | −$17.5K | −3.9%108.4K after | |
| Feb 20, 2025 (view filing) | Feb 18 | 2 days | Sagartz John EChief Strategy Officer | SSale | −2.11K | $3.94 | −$8.33K | −0.3%707.8K after | |
| Feb 20, 2025 (view filing) | Feb 18 | 2 days | Leasure Robert Jr.President and CEO | SSale | −73.6K | $3.82 | −$281.2K | −7.1%956.6K after | |
| Feb 4, 2025 (view filing) | Jan 31 | 4 days | Leasure Robert Jr.President and CEO | SSale | −22.7K | $4.15 | −$94.2K | −2.2%1.03M after | |
| Feb 4, 2025 (view filing) | Jan 31 | 4 days | Taylor BethChief Financial Officer | SSale | −2.05K | $4.47 | −$9.18K | −1.8%112.7K after | |
| Feb 4, 2025 (view filing) | Jan 31 | 4 days | Sagartz John EChief Strategy Officer | SSale | −2.12K | $4.48 | −$9.49K | −0.3%709.9K after | |
| Feb 4, 2025 (view filing) | Jan 31-Feb 3 | 4 days | Krupp Jeffrey ArthurChief Human Resources Officer | SSale | −2.51K | $4.42 | −$11.1K | −8.1%28.6K after | 2 lots |
| Dec 23, 2024 (view filing) | Dec 19 | 4 days | Landman DavidDirector | PPurchase | +23.5K | $4.25 | +$100.0K | +15.3%176.9K after | |
| Dec 12, 2024 (view filing) | Dec 10 | 2 days | Beattie John GregoryChief Operating Officer | PPurchase | +30.0K | $4.75 | +$142.5K | +22.8%161.8K after | |
| Dec 10, 2024 (view filing) | Dec 10 | Same day | Brown NigelDirector | PPurchase | +7.50K | $4.26 | +$31.9K | +12.9%65.5K after | |
| Dec 10, 2024 (view filing) | Dec 6 | 4 days | Harrington Michael JDirector | PPurchase | +10.0K | $3.98 | +$39.8K | +36.4%37.5K after | |
| Dec 10, 2024 (view filing) | Dec 6 | 4 days | Landman DavidDirector | PPurchase | +100.0K | $4.14 | +$414.0K | +187.5%153.3K after | |
| Jan 25, 2024 (view filing) | Jun 7, 2019 | 1,693 daysLate | Leasure Robert Jr.President and CEO | PPurchase | +7.50K | $1.98 | +$14.8K | +7.7%105.0K after | |
| Dec 15, 2023 (view filing) | Dec 14 | 1 day | Garrett MichaelChief Commercial Officer | PPurchase | +5.00K | $2.83 | +$14.2K | +43.6%16.5K after | |
| Dec 15, 2023 (view filing) | Dec 14 | 1 day | Beattie John GregoryChief Operating Officer | PPurchase | +48.0K | $3.12 | +$149.7K | +75.2%111.8K after | |
| Mar 16, 2023 (view filing) | Mar 14 | 2 days | Sagartz John EChief Strategy Officer | PPurchase | +5.10K | $4.91 | +$25.0K | +0.7%692.0K after | |
| Feb 24, 2023 (view filing) | Feb 22 | 2 days | Beattie John GregoryChief Operating Officer | PPurchase | +5.00K | $6.99 | +$35.0K | +8.5%63.8K after | |
| Dec 29, 2022 (view filing) | Dec 9 | 20 daysLate | Pitchford William DChief Human Resources Officer | SSale | −2.12K | $5.82 | −$12.4K | −2.8%74.1K after | |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Neff R MatthewDirector | SSale | −1.00K | $6.12 | −$6.12K | −1.6%62.4K after | |
| Nov 3, 2022 (view filing) | Nov 1 | 2 days | Neff R MatthewDirector | SSale | −1.00K | $21.13 | −$21.1K | −1.6%63.4K after | 2 lots |
| Oct 18, 2022 (view filing) | Oct 17 | 1 day | Neff R MatthewDirector | SSale | −1.00K | $19.10 | −$19.1K | −1.5%64.4K after | |
| Sep 19, 2022 (view filing) | Sep 15 | 4 days | Garrett MichaelChief Commercial Officer | PPurchase | +1.00K | $23.06 | +$23.1K | +100.0%2.00K after | |
| Sep 13, 2022 (view filing) | Sep 9 | 4 days | Beattie John GregoryChief Operating Officer | PPurchase | +8.90K | $22.34 | +$198.8K | +20.8%51.7K after | |
| Mar 16, 2022 (view filing) | Mar 15 | 1 day | Harkness JamesChief Operating Officer, RMS | PPurchase | +39.0K | $19.65 | +$765.6K | New position39.0K after | 2 lots |
| Feb 23, 2022 (view filing) | Feb 22 | 1 day | Downing Philip ASr. VP, Preclinical Srvcs. | PPurchase | +2.00K | $23.97 | +$47.9K | +5.0%42.2K after | |
| Feb 22, 2022 (view filing) | Feb 18 | 4 days | Taylor BethVP- Finance & CFO | PPurchase | +5.00K | $23.07 | +$115.3K | +6.3%83.9K after | |
| Feb 22, 2022 (view filing) | Feb 17-18 | 5 days | Davis Gregory ColeDirector | PPurchase | +5.00K | $22.39 | +$111.9K | +15.3%37.7K after | 3 lots |
| Feb 22, 2022 (view filing) | Feb 18 | 4 days | Garrett MichaelChief Commercial Officer | PPurchase | +1.00K | $23.50 | +$23.5K | New position1.00K after | |
| Feb 18, 2022 (view filing) | Feb 18 | Same day | Pitchford William DChief HR Officer | PPurchase | +3.50K | $21.12 | +$73.9K | +4.8%76.2K after | |
| Feb 18, 2022 (view filing) | Feb 16-18 | 2 days | Beattie John GregoryChief Operating Officer | PPurchase | +11.4K | $22.71 | +$258.9K | +36.3%42.8K after | 3 lots |
| Feb 17, 2022 (view filing) | Feb 17 | Same day | Leasure Robert Jr.President and CEO | PPurchase | +5.00K | $23.03 | +$115.2K | +1.8%285.2K after | |
| Feb 17, 2022 (view filing) | Feb 17 | Same day | Sagartz John EChief Strategy Officer | PPurchase | +2.51K | $19.95 | +$50.0K | +0.4%681.0K after | |
| Jan 12, 2022 (view filing) | Dec 22, 2021 | 21 days | Downing Philip ASr. VP, Preclinical Srvcs. | SSale | −3.06K | $43.04 | −$131.6K | −7.1%40.2K after | Amended |